Showing posts with label WIPO. Show all posts
Showing posts with label WIPO. Show all posts

Sunday, September 1, 2013

WIPO (and others) Release Global Innovation Index—A Wealth of Interesting Information

The World Intellectual Property Organization, Cornell University and INSEAD released the 417 page Global Innovation Index (Report) recently (here).  The Report attempts to measure and evaluate innovation by country and includes discussions concerning regional hubs, innovation clusters and enterprise champions.  The Report also includes specific country data reports on innovation as well as various data rankings such as YouTube video uploads, National Feature Films Produced, Royalties and License Fee Receipts, Daily Newspaper Circulation, Venture Capital Deals, Expenditure on Education, Press Freedom, Scientific and Technical Publications and Wikipedia edits by country (and so much more).  The press release for the Report states: “Despite the economic crisis, innovation is alive and well. Research and development spending levels are surpassing 2008 levels in most countries and successful local hubs are thriving. A group of dynamic middle- and low-income countries – including China, Costa Rica, India, and Senegal - are outpacing their peers, but haven’t broken into the top of the GII 2013 leader board.”  The top ten countries are:

  1. Switzerland (Number 1 in 2012)
  2. Sweden (2)
  3. United Kingdom (5)
  4. Netherlands (6)
  5. United States of America (10)
  6. Finland (4)
  7. Hong Kong (China) (8)
  8. Singapore (3)
  9. Denmark (7)
  10. Ireland (9)

While the United States of America moved up from 10 to 5 this year compared to 2012 and Singapore dropped from 3 to 8, the Report notes that the criteria for ranking changed this year and that:

Singapore and the United States of America (USA) would have kept their 2012 rankings (3rd and 10th, respectively) had we kept the 2012 framework unchanged while updating the database; Singapore drops five spots and the USA gains five as a result of adjustments to the framework in 2013.

The changes are noted in Table 1 on page 50 with discussion on following pages. 

In discussing research and development expenditures, the press release paints an upbeat picture:

“On the research and development (R&D) front, GII 2013 brings a dose of cautious optimism: despite adversity and tightened budget policies, R&D expenditures have grown since 2010. On the business front, the R&D expenditures of top 1,000 R&D spending companies have grown between 9 and 10 % in 2010 and 2011. A similar pattern has been observed in 2012.

A most remarkable characteristic of that trend is that emerging markets have increased their R&D faster than high-income countries. Over the last five years, China, Argentina, Brazil, Poland, India, Russia, Turkey and South Africa (in that order) have been at the forefront of this phenomenon. Emerging markets, and notably China, are also largely driving the growth in patent filings worldwide.

“Growing research and development investments and the rising number of intellectual property patents filed are tangible examples of a growing commitment to innovation,” said Mr. Li Yingtao, Head of Huawei’s 2012 R&D laboratories. “In the global economy, innovation from anywhere can drive change and create new opportunities everywhere. Everyone concerned with innovation as a catalyst for economic and social development needs to remain focused on how the value of innovation is to transform industries, businesses and people’s lives, not just locally but across the world.”

In examining the BRIC countries compared to the rise of other “emerging middle-income nations”, the Report states that:

The BRICs have experienced a relative stagnation or mostly a drop in innovation ranks in 2013 as compared to 2012, repeating the experience of last year (2011 to 2012): China (35th; a decrease of one spot from 2012 and six from 2011), the Russian Federation (62nd; a decrease of 11 positions from 2012 and six from 2011), Brazil (64th; a decrease of six spots from 2012 and 17 from 2011), and India (66th; a decrease of two positions from 2012 and four from 2011). In this context, other emerging middle-income nations are increasing their innovation ranks rapidly: Mexico (63rd; an increase of 16 positions from 2012 and 18 from 2011), Indonesia (85th; an increase of 15 from 2012 and 14 from 2011), and others (the Plurinational State of Bolivia, Cambodia, Costa Rica, Ecuador, Uganda, and Uruguay) all increased their rankings by more than 15 positions this year . . . .

As a big fan of “The Land of Enchantment” (a truly special place), I was pleased to find that:

Top world R&D investing countries host top world R&D investing regions. The top region for R&D in the OECD is New Mexico (United States of America, or USA). This state devotes more than 7% of its GDP to R&D, followed by Massachusetts (USA), which invests slightly less than 7% of its GDP in R&D.

And, as a resident of California, it was nice to hear that inventors in the state are collaborative folks with strong networks:

The regions that invest the most in R&D and account for most of the world’s patent applications adopt different innovation modes. In fact, some rely more on networks than others. For instance, the propensity to carry out research with multiple inventors located in different regions varies across sectors and countries. The possibility that inventors located in one region may collaborate with others located elsewhere is shaped by several factors, including the institutional environment of the countries involved. In general, however, collaborations are increasingly important for innovation. In the telecommunication sector, the share of patents with at least two co-inventors located in two different regions increased from 7.9% in the late1970s to 16.2% in 2005–07. In this sector, California performs like a star; the share of patents applied for by residents of California with at least one co-inventor located in another region, in the USA or abroad, is around 24%, but the region has the world’s widest network in terms of the geographic location of partners.

For the patent focused folks, there are PCT patent application rankings by region within specific countries on page 95.  The top five are Southern Kanto in Japan, California in the United States, Capitol Region in South Korea, Kinki in Japan, and Guangdong in China.

The Report also notes the relationship between public policy and the growth of a technology hub by examining Huawaei’s development in depth:

 In 1980, Shenzhen was a small fishing village on the Chinese mainland close to Hong Kong (China). To fuel the growth of the city, public policies were enacted to ease the movement of talent, expertise, and investment into the area, both from across China and from over seas. International corporations were encouraged to invest and create operations in Shenzhen. Policies supported the construction of public and private infra- structure, from business parks and transportation and communication links to hotels and residential developments. The city’s population has grown from 20,000 to 15.5 mil- lion people in just over 30 years; Shenzhen is thriving as a high-technology innovation cluster and sup- porting markets around the world.3 Huawei was established in Shenzhen in 1987 as a sales company, reselling technology developed by a third party.

The Report discusses the importance of intellectual property rights to Huawei:

The idea that innovation is a fundamental input to socioeconomic development is a strong belief held within the corporate culture of any successful innovative company. Commercial companies that invest significantly in R&D do so on the basis that their innovation will have the opportunity to earn a return on those investments. Without a return on innovation, the ability to continually innovate diminishes. This ability requires that IPRs be both respected and protected. This is a key factor in establishing a culture of innovation and achieving scale.8 As an example, Huawei has entered into numerous cross-licensing agreements with industry peers since 2002 and has paid a large amount in patent licensing fees to use third-party intellectual property. In 2012 alone, Huawei paid some US$300 million in patent licensing fees. Huawei also licenses its own intel- lectual property. In fact, Huawei is one of the leading IPR holders in the ICT industry. By December 2012, Huawei had filed 41,948 patent applications in China, 12,453 inter- national Patent Cooperation Treaty patent applications, and 14,494 patent applications outside China.

Huawei attaches greater importance to the commercial value and quality of its IPRs than to their actual quantity, however. Huawei takes the lead in holding patents in such technical fields as long-term evolution, next-generation wireless communications technology, fibre- to-the-home networks, optical transport networks, and the G.711.1 audio standard on fixed broadband networks worldwide. Huawei strategically maintains its patent application level at 3,000 to 4,000 applications annually.

The Report includes other specific case studies concerning Uruguay, India, Tunisia, and Morocco.  On page 327 on the Report, there is a ranking of University and Industry Collaboration by country.  The top ten include: Switzerland, United Kingdom, United States, Finland, Singapore, Belgium, Sweden, Israel, Qatar, and the Netherlands (with Germany at 11) (in response to a survey question).  Enjoy!

Tuesday, February 26, 2013

Dogs and Cats Living Together? The New WIPO, WTO and WHO Book.

On February 5, 2013, WIPO, the WTO, and the World Health Organization issued a jointly authored book titled, “Promoting Access to Medical Technologies and Innovation – Intersections between public health, intellectual property and trade.”  The 253 page book is an ambitious one—tackling the intersection of innovation and access.  The press release states:

Today’s health policy‑makers need a clear understanding both of the innovation processes that lead to new technologies and of the ways in which these technologies are disseminated in health systems. This study captures a broad range of experience and data in dealing with the interplay between intellectual property, trade rules and the dynamics of access to, and innovation in, medical technologies.

The study is intended to inform ongoing technical cooperation activities undertaken by the three organizations and to support policy discussions. Based on many years of field experience in technical cooperation, the study has been prepared to serve the needs of policy‑makers who seek a comprehensive presentation of the full range of issues, as well as lawmakers, government officials, delegates to international organizations, non‑governmental organizations and researchers.

The book has four parts: 1) Medical Technologies: The Fundamentals; 2) The Policy Context for Action for Innovation and Access; 3) Medical Technologies: The Innovation Dimension; and 4) Medical Technologies: The Access Dimension.  The study is very complete and attempts to tie together a lot of different concepts, and generally does so well (although I know I need to spend more time with it).  Some interesting items in the report include: a statement that a goal of the report is to find some “policy coherence” between the three organizations and that the report was made in a spirit of cooperation began by the Doha Declaration, the WIPO Development Agenda, and the WHO Global Strategy and Plan of Action for Global Health; a specific section on traditional medicine and knowledge; a statement that “[t]he overarching condition for providing access to needed medical technologies and health services is a functioning national healthcare system”; a dizzying chart concerning Tanzania’s medical supply systems; placing the human right to health within the intellectual property law context; and a helpful table breaking down pharmaceutical related provisions in FTAs.

On the Bayh-Dole Act and similar policies, the report states:

Such policies, and a general trend towards more active management of technologies created through publicly funded research, are leading to the steady accumulation of publicly held patent portfolios, including on key upstream technologies that provide platforms for a range of new medical technologies.

This report appears to be a great step toward harmonizing a lot of concepts in public health and intellectual property.  There is no question that trying to find solutions to the problems outlined in the report requires expertise in a lot of different areas and much collaboration. 

Monday, September 21, 2009

Aggregate IP Data is Nice, But What About All Those Other Countries?

I guess I am a micro-man at heart, and I have never quite understood what one is to make of macro data on IP filings and registrations. Even without seeing the most recent data international data, most of us can usually predict in which countries most patents and trade marks are being filed and registered. More challenging are the implications of these data. I thought about this again in reading the blogpost of my fellow IP Finance blogger, Eva Lehnert, who brought to the readership's attention a WIPO Report on trends in intellectual property activity here. As noted, the report brings various data on filing and registration patterns for patents and utility models, trade marks and industrial designs.

Let's consider some of additional results to those previously reported in Lehnert's earlier blogpost:
1. Patent fillings were down in 2007; 59.2% of applications were filed in China, Japan, and the USA.

2. The patent offices of Japan, USA, Republic of Korea, China and the EPO accounted for 74.4% of the total patent grants.

3. There are at least 4.2 million pending patent applications, with the USA accounting for 28% of the backlog.

4. Trade mark registrations were up 6% in 2007, with the most noticeable increase being in Brazil Nearly one-fifth of trade marks were filed in China in 2007.

5. Japan, USA, France and Germany account for nearly 20% of trade marks in force. and nearly 125,000 trade marks in force were registered before 2007.

6. France accounted for the largest number of industrial designs in force in 2007.
Keeping these data in mind, I found a bit curious the statement made in the report's forward by the WIPO Director General Dr. Francis Gurry:
“History has shown … that companies and countries which continue to invest in new products and innovation during times of economic recession will be those that will be best positioned to take advantage of the recovery, when it arrives. IP statistics help us to understand the role of the IP system in stimulating and diffusing innovation, promoting markets for new products, and rewarding creativity.”
With all due respect, I do not quite see how these macro data tell us very much beyond the fact that registered IP is still the purview of the traditional filing countries plus China. If growth is what we are concerned about, then what about such countries as India, Brazil (trade marks aside), Russia, Indonesia, Taiwan, Australia, Mexico, South Africa and Singapore? Even if the aggregate filing and registration data do not approach those of larger countries, what is the rate of increase in these countries? Do we observe any relationship between IP activity, on the one hand, and innovation and economic growth, on the other, on a country by country basis?

If WIPO has made these kinds of information available to the public, I would be grateful for further guidance how to obtain them. If not, where is this kind of information available? I, for one, would find this kind of information to be of particular interest.